Exponent, Inc. (NASDAQ:EXPO – Get Free Report) VP Joseph Sala sold 2,066 shares of Exponent stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $56.66, for a total transaction of $117,059.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Exponent Trading Down 1.6%
Shares of EXPO stock opened at $53.67 on Friday. Exponent, Inc. has a 1 year low of $51.91 and a 1 year high of $81.95. The firm’s fifty day moving average price is $66.10 and its two-hundred day moving average price is $69.85. The firm has a market capitalization of $2.60 billion, a P/E ratio of 24.96 and a beta of 0.78.
Exponent (NASDAQ:EXPO – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The business services provider reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.56 by $0.03. Exponent had a net margin of 18.07% and a return on equity of 27.94%. The firm had revenue of $166.30 million for the quarter, compared to analyst estimates of $149.53 million. During the same period in the previous year, the business earned $0.52 EPS. The company’s revenue was up 14.3% compared to the same quarter last year. As a group, equities research analysts forecast that Exponent, Inc. will post 2.28 EPS for the current fiscal year.
Exponent Announces Dividend
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Conestoga Capital Advisors LLC grew its stake in Exponent by 1.3% in the 4th quarter. Conestoga Capital Advisors LLC now owns 2,392,499 shares of the business services provider’s stock valued at $166,183,000 after buying an additional 31,303 shares during the last quarter. Morgan Stanley grew its stake in Exponent by 3.6% in the 4th quarter. Morgan Stanley now owns 1,154,210 shares of the business services provider’s stock valued at $80,172,000 after buying an additional 39,865 shares during the last quarter. First Trust Advisors LP grew its stake in Exponent by 7.4% in the 1st quarter. First Trust Advisors LP now owns 964,814 shares of the business services provider’s stock valued at $62,954,000 after buying an additional 66,471 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Exponent by 2.3% in the 1st quarter. Dimensional Fund Advisors LP now owns 918,885 shares of the business services provider’s stock valued at $59,958,000 after buying an additional 20,270 shares during the last quarter. Finally, Norges Bank acquired a new position in Exponent in the 4th quarter valued at about $51,166,000. Institutional investors and hedge funds own 92.37% of the company’s stock.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating on the stock in a research note on Thursday, March 26th. UBS Group lowered their price objective on shares of Exponent from $85.00 to $75.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research note on Tuesday, April 21st. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $85.00.
Get Our Latest Report on Exponent
Exponent Company Profile
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
Featured Articles
- Five stocks we like better than Exponent
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
